These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 16288954
1. The Na+ binding channel of human coagulation proteases: novel insights on the structure and allosteric modulation revealed by molecular surface analysis. Silva FP, Antunes OA, de Alencastro RB, De Simone SG. Biophys Chem; 2006 Feb 01; 119(3):282-94. PubMed ID: 16288954 [Abstract] [Full Text] [Related]
2. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors? Silva FP, De-Simone SG. Bioorg Med Chem; 2004 May 15; 12(10):2571-87. PubMed ID: 15110839 [Abstract] [Full Text] [Related]
3. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding. Schmidt AE, Stewart JE, Mathur A, Krishnaswamy S, Bajaj SP. J Mol Biol; 2005 Jul 01; 350(1):78-91. PubMed ID: 15913649 [Abstract] [Full Text] [Related]
4. Regulation of the catalytic function of coagulation factor VIIa by a conformational linkage of surface residue Glu 154 to the active site. Shobe J, Dickinson CD, Ruf W. Biochemistry; 1999 Mar 02; 38(9):2745-51. PubMed ID: 10052945 [Abstract] [Full Text] [Related]
5. Contribution of explicit solvent effects to the binding affinity of small-molecule inhibitors in blood coagulation factor serine proteases. Abel R, Salam NK, Shelley J, Farid R, Friesner RA, Sherman W. ChemMedChem; 2011 Jun 06; 6(6):1049-66. PubMed ID: 21506273 [Abstract] [Full Text] [Related]
6. Energetics of thrombin-thrombomodulin interaction. Vindigni A, White CE, Komives EA, Di Cera E. Biochemistry; 1997 Jun 03; 36(22):6674-81. PubMed ID: 9184147 [Abstract] [Full Text] [Related]
8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ, Almond HR, Hecker LR, Schott MR, Yabut SC, Zhang HC, Andrade-Gordon P, Corcoran TW, Giardino EC, Kauffman JA, Lewis JM, de Garavilla L, Haertlein BJ, Maryanoff BE. J Med Chem; 2005 Mar 24; 48(6):1984-2008. PubMed ID: 15771442 [Abstract] [Full Text] [Related]
9. Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants. Hopfner KP, Brandstetter H, Karcher A, Kopetzki E, Huber R, Engh RA, Bode W. EMBO J; 1997 Nov 17; 16(22):6626-35. PubMed ID: 9362477 [Abstract] [Full Text] [Related]
10. Molecular Interactions of Thrombin. Tulinsky A. Semin Thromb Hemost; 1996 Nov 17; 22(2):117-24. PubMed ID: 8807707 [Abstract] [Full Text] [Related]
16. Rational engineering of activity and specificity in a serine protease. Dang QD, Guinto ER, di Cera E. Nat Biotechnol; 1997 Feb 30; 15(2):146-9. PubMed ID: 9035139 [Abstract] [Full Text] [Related]
18. High resolution crystal structures of free thrombin in the presence of K(+) reveal the molecular basis of monovalent cation selectivity and an inactive slow form. Carrell CJ, Bush LA, Mathews FS, Di Cera E. Biophys Chem; 2006 Jun 01; 121(3):177-84. PubMed ID: 16487650 [Abstract] [Full Text] [Related]